Navigation Links
Experts Issue Warning on Prostate Hormone Therapy
Date:2/1/2010

People underestimate effect on heart from androgen deprivation, official says

MONDAY, Feb. 1 (HealthDay News) -- Men with prostate cancer and the physicians who treat them are being warned that the androgen-deprivation therapy (ADT) commonly used against the malignancy might increase the risk of heart attack and cardiac death.

"There is a substantial amount of data demonstrating that ADT adversely affects traditional cardiovascular risk factors, including serum lipoproteins, insulin sensitivity and obesity," according to an advisory published online Feb. 1 in Circulation by a group of experts from the American Heart Association, American Cancer Society and the American Urological Association.

The warning is guarded, saying that risks have not been found in all studies. "But we think that physicians treating patients with localized and metastatic prostate cancers as well as patients ought to realize that there are significant risks associated with the use of hormone therapy," said Dr. Otis Brawley, chief medical officer of the American Cancer Society.

ADT reduces or eliminates the male hormones that can promote growth of prostate cancer. About one-third of all men with prostate cancer are given ADT, Brawley noted.

"Many people underestimate the harm of hormonal therapy and overestimate the potential benefits of hormonal therapy," he said.

Six studies -- two done in Europe, four in the United States -- have shown increased incidence of cardiovascular problems in men, Brawley said.

One U.S. study of 37,000 men treated for prostate cancer at Veterans Affairs hospitals found a 27 percent increased risk for heart disease among those given multiple hormone-blocking agents. Surgical removal of the testes was associated with a 40 percent increased risk for heart disease and a more than doubled risk for a heart attack.

"These drugs do have usefulness," Brawley said. But there has been debate about whether ADT should be used in some cases, such as when levels of prostate-specific antigen (PSA), a cancer-associated protein, begin to go up but there are no other signs and symptoms of cancer progression, he said.

"A man has had radical prostatectomy [cancer surgery] and PSA starts rising again," Brawley said. "There has been a debate in the medical profession: Should we start hormonal therapy or just watch it go up and act only if we see the cancer spreading?"

More research is needed to determine the proper course of action in these and other cases where the course of the disease is not clear, the new advisory said.

Meanwhile, "the American Cancer Society is advising that physicians be aware that all hormone therapies for prostate cancer can have an increased risk of cardiovascular disease and diabetes and death," Brawley said. "They can be useful in treatment but should be used with caution."

A need for caution was also emphasized by Dr. Arthur Sagalowsky, a professor of urology and chief of urologic oncology at the University of Texas Southwestern Medical Center in Dallas and one of two urologists representing the American Urological Association on the panel that produced the advisory.

"One needs to be very careful in not overdrawing conclusions beyond what the panel has done," Sagalowsky said.

The risk for cardiac problems should be one of many issues discussed in the treatment of prostate cancer, he said. "It adds to the body of information that I present to patients with prostate cancer when they decide whether or if to begin androgen-deprivation therapy," he said. "How one decides will depend on the circumstances of the patient's prostate cancer, and this individual side effect is one of the issues that enter into the discussion."

More information

The U.S. National Cancer Institute has more on prostate cancer.



SOURCES: Otis Brawley, M.D., chief medical officer, American Cancer Society, Atlanta; Arthur Sagalowsky, M.D., professor, urology, and chief, urologic oncology, University of Texas Southwestern Medical Center, Dallas; Feb. 1, 2010, Circulation, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Ask the non-experts
2. Experts Push 7 Steps to Heart Health
3. Life-Saving Emergency Supplies and Experts Arrive in Port-au-Prince
4. Airport Full Body Scanners Pose No Health Threat: Experts
5. Experts Say CPR by Untrained Bystander a Good Idea
6. Transplant infectious disease experts provide pandemic guidance
7. Leading Plastic Surgery Experts Available to Discuss Proposed Cosmetic Surgery Tax
8. 10 x 20: ID experts call for 10 new antibiotics by 2020
9. Experts Examine Possible Links Between Climate Change and Infectious Disease Transmission
10. Lung cancer experts hold roundtable on new staging guide
11. Experts Urge School Screening of Athletes Hearts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... Texas , Oct. 11, 2017  True ... services, has amplified its effort during National Breast ... about hereditary cancer risks. ... of Clinical Oncology calculated that more than 10 ... have inherited mutations in BRCA1 or BRCA2 and have ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
Breaking Medicine Technology: